Search results for "Fluid Management"

showing 2 items of 2 documents

Total plasma protein in very preterm babies: prognostic value and comparison with illness severity scores

2013

International audience; OBJECTIVE: We aimed to investigate the predictive value for severe adverse outcome of plasma protein measurements on day one of life in very preterm infants and to compare total plasma protein levels with the validated illness severity scores CRIB, CRIB-II, SNAP-II and SNAPPE-II, regarding their predictive ability for severe adverse outcome. METHODS: We analyzed a cohort of infants born at 24-31 weeks gestation, admitted to the tertiary intensive care unit of a university hospital over 10.5 years. The outcome measure was "severe adverse outcome" defined as death before discharge or severe neurological injury on cranial ultrasound. The adjusted odd ratio (aOR) and 95%…

PediatricsMultivariate analysisCritical Care and Emergency MedicineEpidemiology[ SDV.MHEP.PED ] Life Sciences [q-bio]/Human health and pathology/Pediatricslcsh:MedicinePediatricslaw.inventionCohort Studies0302 clinical medicinelawInfant Very Low Birth Weight030212 general & internal medicineProspective StudiesPediatric Epidemiologylcsh:ScienceMultidisciplinaryArea under the curveBlood ProteinsIntensive care unit3. Good healthCohortMedicineInfant PrematureResearch Articlemedicine.medical_specialtyPediatric Critical CareClinical Research DesignBirth weightFluid Management03 medical and health sciencesHypoproteinemia030225 pediatricsInternal medicinemedicineHumansPrematureRetrospective StudiesNutrition[SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/PediatricsReceiver operating characteristicbusiness.industryVery Low Birth Weightlcsh:RInfant NewbornInfantmedicine.diseaseNewbornConfidence intervallcsh:QNeonatologybusiness
researchProduct

Pruritus precipitated by hydroxyethyl starch: a review.

2005

Summary Hydroxyethyl starch (HES) is widely used for fluid management in broad populations of patients, particularly in the surgery and intensive care settings. Pruritus, often manifested as pruritic crises, is increasingly being recognized as a common major adverse effect of HES administration. This iatrogenic form of pruritus is frequently severe and protracted with a serious negative impact on patient quality of life, including sleep disturbance, disruption of daily routine and mental distress. Such pruritus is generally refractory to available therapies and can persist for up to 12–24 months. All currently clinically available HES solutions entail the risk of pruritus, including those o…

medicine.medical_specialtyPlasma SubstitutesDermatologyFluid managementHydroxyethyl starchHydroxyethyl Starch DerivativesQuality of lifeIntensive careMedicineHumansTissue Distributionskin and connective tissue diseasesIntensive care medicineAdverse effectreproductive and urinary physiologyDaily routineHetastarchSleep disorderintegumentary systemDose-Response Relationship Drugbusiness.industryPruritusmedicine.diseaseSurgeryDrug Eruptionsbiological phenomena cell phenomena and immunitybusinessmedicine.drugThe British journal of dermatology
researchProduct